Extranodal Marginal Zone MALT-Lymphoma
Keywords:
-Abstract
-
Downloads
References
Fung YC. Atlas of clinical oncology : Malignant lymphomas, 2002:126-34.
Wright HD. The Non-Hodgkin's Lymphomas: Second Edition, 1997:495-511.
Franco C, et al. MALT Lymphomas : Hematology, 2001:241-53.
Dierlamm J, Beans M, Stefanova-Ouzounova M, Hinz K, Wodarska I, Maes B. Detection of t(11;18) (q21;q21) by interphase fluorescence in situ hybridization using API2 and MLT specific probes. Blood 2000;96:2215-8.
Liu H, Ye H, Dogan A, Ranaldi R, Hamoudi R, Bearzi I. T(1;18)(q21;21) is associated with advanced mucosa-associated lymphoid tissue lymphoma that expresses nuclear BCL10. Blood 2001;98:1182-7.
Maes B, Demunter A, Peeters B, De Wolf-Peeters C. BCL10 mutation does not represent an important pathologenic mechanism in gastric MALT- type lymphoma and the presence of the API2-MALT fusion is associated with aberrant nuclear BCL10 expression. Blood 2002:99:1398-404.
Starostik P, Patzner J, Greiner A, Schwarz S, Kalla J, Ott G. Gastric marginal zone B cell lymphoma of MALT type develop along 2 distinct pathologenetic pathways. Blood 2002;99:3-9.
Wotherspoon AC, Pan LX, Diss TC, Isaacson PG. Cytogenetic study of B cell lymphoma of mucosa-associated lymphoid tissue. Cancer Genet Cytogenet 1992,58.35-8.
Isaacson PG. Gastric MALT lymphoma: from concept to cure. Ann Oncol 1999:10:637-45.
Azab MB, Henry-Amaer M, Rougier P, et al. Prognostic factors in primary gastrointestinal non Hodgkin's lymphoma. Cancer 1989;64:1208-17.
Jason C. Treatment of gastric lymphoma. P&S Medical Review 1993;1:1-6.
Bertoni F, Conconi A, Capella C, Motta T, Giardini R, Ponsoni M. Molecular follow-up in gastric mucosa-associated lymphoid tissue lymphomas: eary analysis of the LY03 cooperative trial. Blood 2002;99:2541-4
Weston AP, Benerjee SK, Horvat RT, Zoubine MN, Campbell DR, Cherian R. Prospective long-term endoscopic and histilogic follow-up of gastric lymphoproliferative disease of early stage TE low-grade B-cell mucosa-associated lymphoid tissue type following Helicobacter pylori eradication trreatment. Int J Oncol 1999;15.899-907.
Liu H, et al. t(11;18) is a marker for all stage gastric MALT lymphoma that will not response to H. pylori eradication. Gastroenterology 2002;122:1286-94.
Schechter NR, Portlock CS, Yahalom J. Treatment of mucosa-associated lymphoid tissue lymphoma of the stomuch with radiation alone. J Clin Oncol 1998;16: 1916-21.
Zucca E, Roggero E, Traulle C, et al. Early interim report of the LY03 randomised cooperative trial of observation vs chlorambucil after anti Helocobacter therapy in low-grade gastric lymphoma. Ann Oncol 1999;10(suppl 3):25.
Solidoro A, Payet C, Sanchez-Liton J, et al. Gastric lymphom: Chemotherapy as aprimary treatment. Semin Surg Oncol 1990;6:218-25
Annarita C, Catherine T, Giovani M, Andres F, Liliana D, Fedro P, et al. IELSG phase II study of rituximab in MALT lymphoma: final result .abstract in ASCO 2002; No.1067
Maor MH, Velasquez WS, Fuller LM, et al. Stomuch conservation in stages IE and IIE gastric non-Hodgkin's lymphoma. J Clin Onco 1990;8:266-71
Salem AP, Jones VD. Treatment of malignant neoplasms of the mucosa-associated lymphoid tissues. The Non-Hodgkin's lymphomas 1997;2:1989-95.
Shilpa AR, Prakash PH, Pinky T. Mucosa Associated Lymphoid Tumour (MALT) of the lleum. Bombay Hospital Journal 1999;41:349.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
